We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+11.62%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$11.1B
AUM Growth
+$2.91B
Cap. Flow
+$2.44B
Cap. Flow %
22.01%
Top 10 Hldgs %
80.14%
Holding
1,432
New
428
Increased
273
Reduced
246
Closed
471

Sector Composition

Rank Sector Weight
1 Technology 2.19%
2 Financials 1.49%
3 Industrials 1.31%
4 Consumer Discretionary 0.86%
5 Energy 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOW
926
DELISTED
WideOpenWest
WOW
$59K ﹤0.01%
+16,309
New +$58.2K
VXRT
927
DELISTED
Vaxart
VXRT
$58.3K ﹤0.01%
+44,864
New +$47K
SRTA
928
Strata Critical Medical Inc
SRTA
$525M
$58K ﹤0.01%
+20,340
New +$62.8K
OLO
929
DELISTED
Olo Inc
OLO
$55.7K ﹤0.01%
10,146
-12,829
-56% -$70K
UP icon
930
Wheels Up
UP
$191M
$53.7K ﹤0.01%
+936
New +$61.6K
CRBU icon
931
Caribou Biosciences
CRBU
$165M
$52.7K ﹤0.01%
+10,254
New +$63.2K
RPTX
932
DELISTED
Repare Therapeutics
RPTX
$51.6K ﹤0.01%
10,956
-4,729
-30% -$30.3K
AXTI icon
933
AXT Inc
AXTI
$4.83B
$51.3K ﹤0.01%
+11,174
New +$38K
COMP icon
934
Compass
COMP
$9.52B
$48.5K ﹤0.01%
13,481
-53,446
-80% -$189K
RGTI icon
935
Rigetti Computing
RGTI
$5.89B
$47.5K ﹤0.01%
+31,066
New +$44.8K
MYPS icon
936
PLAYSTUDIOS Inc
MYPS
$86.3M
$46.9K ﹤0.01%
16,861
+5,929
+54% +$13.8K
CATX icon
937
Perspective Therapeutics
CATX
$342M
$46.4K ﹤0.01%
+3,899
New +$33.2K
STXS icon
938
Stereotaxis
STXS
$143M
$44.9K ﹤0.01%
+17,148
New +$40.8K
DHC
939
Diversified Healthcare Trust
DHC
$2.04B
$44.6K ﹤0.01%
+18,113
New +$51.9K
MAXN
940
DELISTED
Maxeon Solar Technologies
MAXN
$43.5K ﹤0.01%
+131
New +$58.9K
LCID icon
941
Lucid Motors
LCID
$2.6B
$42.8K ﹤0.01%
1,500
-5,141
-77% -$164K
CYH icon
942
Community Health Systems
CYH
$415M
$39.5K ﹤0.01%
11,275
-14,248
-56% -$48.2K
CTMX icon
943
CytomX Therapeutics
CTMX
$750M
$39.4K ﹤0.01%
+18,056
New +$33.3K
PXLW icon
944
Pixelworks
PXLW
$41M
$38.6K ﹤0.01%
+1,247
New +$33.1K
ERAS icon
945
Erasca
ERAS
$6.29B
$38.4K ﹤0.01%
+18,638
New +$37.3K
LVO icon
946
LiveOne
LVO
$60.4M
$36.4K ﹤0.01%
+1,867
New +$29.7K
CERS icon
947
Cerus
CERS
$508M
$32.8K ﹤0.01%
+17,364
New +$35.4K
CHRS icon
948
Coherus Oncology
CHRS
$192M
$31.6K ﹤0.01%
13,222
-60,340
-82% -$148K
NRDY icon
949
Nerdy
NRDY
$93.5M
$29.7K ﹤0.01%
+10,216
New +$31.5K
ABUS icon
950
Arbutus Biopharma
ABUS
$907M
$27K ﹤0.01%
10,482
-7,277
-41% -$18.8K

Similar funds

Brevan Howard Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Brevan Howard Capital Management held 1,432 positions worth $11.1B, up 36% from $8.18B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Brevan Howard Capital Management deployed $2.44B of net new capital in Q1 2024, opening 428 new positions and adding to 273 existing holdings. Its largest new stake was CME Group: 102,553 shares worth $22.1M.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 1.7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Home Depot, an estimated $14.9M trimmed.

  • Brevan Howard Capital Management's largest Q1 2024 buy was CME Group: 102,553 shares worth $22.1M.
  • Brevan Howard Capital Management added most to Workday in Q1 2024, an estimated $31.9M increase.
  • Brevan Howard Capital Management's biggest Q1 2024 reduction was Home Depot, cutting an estimated $14.9M.
  • Brevan Howard Capital Management fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $111M.
  • Brevan Howard Capital Management's ten largest holdings make up 80% of its $11.1B portfolio in Q1 2024.
  • Brevan Howard Capital Management opened 428 new positions and closed 471 in Q1 2024.
  • Brevan Howard Capital Management's portfolio value rose 36% quarter-over-quarter to $11.1B.

Based on Brevan Howard Capital Management's 13F filing for Q1 2024, filed 15 May 2024.